3 HealthTech Stocks up over 70% past 10 days (BVS stock, APYX stock, AUTL stock)
Today, the screeners at HealthTechMovers.com picked up 3 HealthTech Stocks up over 70% past 10 days and have been added to our watchlist. These are very volatile stocks so please do your own research before you make any investments. While we list the ratings of various 3rd party services, we're not recommending these stocks and we're not paid by the featured tickers, we simply report the big movers. If the editor has a position, it will be noted below the charts.
FinMarketNews.com is looking into these tickers DAWN, MTDR, AVY, CMC, MNST, RTX and more.
One resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
Bioventus, BVS
Summary: Bioventus Inc. delivers clinically proven, cost-effective products which help people heal quickly and safely. It includes offerings for osteoarthritis, surgical and non-surgical bone healing. Bioventus Inc. is based in DURHAM, N.C.
Recent BVS Stock Price (approx 10:00am EST.): $2.30
Previous Close for BVS Stock: $2.09
Percentage Price Change Past 10 Days for BVS stock: +120%
TipRanks.com reports that Bioventus stock currently has 3 analysts offering 12-month price targets and the consensus is a Hold rating for BVS stock with an average price target is $4.00.
Click here to get the full story on BVS stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Apyx Medical Corporation is an energy technology company. It provides products in the cosmetic and surgical markets. The company's Helium Plasma Technology is marketed and sold as Renuvion(R) in the cosmetic surgery market and J-Plasma(R) in the hospital surgical market. Apyx Medical Corporation, formerly known as Bovie Medical Corporation, is based in FL, United States.
Recent APYX Stock Price (approx 10:00am EST.): $6.35
Previous Close for APYX Stock: $6.02
Percentage Price Change Past 10 Days for APYX stock: +73%
TipRanks.com reports that Apyx Medical stock currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating for APYX stock with an average price target is $6.67.
Click here to get the full story on APYX stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Summary: Autolus Therapeutics plc is a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies. The company's pipeline of product candidate involved in development for the treatment of haematological malignancies and solid tumours. Autolus Therapeutics plc is based in London, United Kingdom.
Recent AUTL Stock Price (approx 10:00am EST.): $3.27
Previous Close for AUTL Stock: $3.2
Percentage Price Change Past 10 Days for AUTL stock: +70%
TipRanks.com reports that Autolus Therapeutics stock currently has 5 analysts offering 12-month price targets and the consensus is a Moderate Buy rating for AUTL stock with an average price target is $7.50.
Click here to get the full story on AUTL stock >>
Pricing & Percentages as of approximately 10:00am EST.
-----------------------------------------------------------------------------------------
Just a reminder, one resource you need to consider using Tipranks.com where as a premium member you get access to all buy ratings, price targets and insider trading signals. Click here for more on Tipranks.com.
The other great tool for charting is TradingView.com, so you might want to check that out too.
The information in this article was pulled from third part services. The prices listed above are not real-time and will be delayed at least 15 minutes.
FinMarketNews.com keeps investors informed of the top moving stocks within each sector including Health & Biotech, Technology, Energy, Metals & Mining, Financial, Consumer, Communication Services and more. We provide investors with timely information regarding top moving stocks that is sourced from our proprietary stocks screens, partner stock analysts and breaking news that identify and monitor stocks that are on the move. Join thousands of investors who already signed up for our free subscription to FinMarketNews.com.